Insilico Medicine Introduces AI-Generated Drug for Idiopathic Pulmonary Fibrosis: A Promising…
Insilico Medicine, a Hong Kong-based biotechnology startup, has introduced a new drug called "INS018_055" for the treatment of idiopathic pulmonary fibrosis, according to Alex Zhavoronkov, the founder and CEO of Insilico, during an…